Results
Mankind Pharma Reports FY26 Revenue Growth to ₹14,278 Crores
Mankind Pharma reported strong FY26 performance with revenue of ₹14,278 crores showing 17% YoY growth and adjusted EBITDA margin of 25.4% across consolidated operations.
The company issued notice for
